JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 ,inter alia, to consider and approve Audited Financials ....
JHS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
JHS Svendgaard Laboratories has informed the stock exchanges that its Board of Directors will meet on Tuesday, May 27, 2025, to consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2025. This is a fresh scheduling after the company had earlier deferred the financial results agenda from its May 17, 2025 board meeting, while the meeting itself was held to transact other business. The trading window for insiders has been closed since April 1, 2025 and will stay shut until 48 hours after the results are announced.
This is a procedural filing ahead of the FY25 results announcement, with no actual numbers disclosed yet. Investors should wait for the May 27 outcome to gauge the company's full-year performance; the prior deferral of the results item is worth noting but its reason has not been disclosed.